American Healthcare REIT, Inc.

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

American Healthcare REIT, Inc. trades at $57.7, in a confirmed uptrend and 6 weeks into that stage. That is +17.2% against its own 200-day average. It sits at 100% of a 52-week range of $40 to $58. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 3 straight weeks.

Today the stock is in a confirmed uptrend — week 6 of stage 2. At $57.7 it trades +17.2% versus its 200-day average and sits at 100% of its 52-week range ($40–$58).

Against the market, two honest reads. Cumulative: over the last 2.5 years the stock moved +340% while the S&P 500 moved +48% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 3 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

→ The trend is one thing; the bill is another. Are you paying up for it? Next: how the P/E reads against its own history.

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

American Healthcare REIT, Inc. trades at 100.3× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 100.3× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

American Healthcare REIT, Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 2 curves, on partial evidence.

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.

4-Factor Sector Score

45.1/100 — rank 9 of 17 in REIT - Healthcare Facilities · 69% evidence confidence

American Healthcare REIT, Inc. scores 45.1 out of 100 against the 17 companies it is compared with in REIT - Healthcare Facilities, ranking 9. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 18.4 + 8.3 + 4.3 + 14.1 = 45.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.

Revenue Revenue is the top line: everything the company billed its customers in the period.

American Healthcare REIT, Inc. reported $0.7 B of revenue in the Mar 26 quarter, +20.4% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 15.3% a year. The last full year, FY25, came in at $2.3 B. The last four reported quarters add to $2.4 B.

American Healthcare REIT, Inc. reported $0.7 B of revenue in the Mar 26 quarter, +20.4% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 15.3% a year. The last full year, FY25, came in at $2.3 B. The last four reported quarters add to $2.4 B.

FY25 revenue came in at $2.3 B (+9.2% on the year), capping 4 years at 15.3% compound. The latest quarter (Mar 26) printed $0.7 B, +20.4% year on year — the 12th consecutive quarter of year-over-year growth.

Pace check: the last four quarters averaged +12.3% growth against the decade's 15.3% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +12.4% over the last 4 quarters against +11.2%/yr over the last 8 — stabilising.

→ Revenue grew — did margins hold as it scaled? Next: 6.2% this quarter (−1.2 pp YoY).

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

American Healthcare REIT, Inc.'s operating margin is 6.2% in the Mar 26 quarter, −1.2 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged 1.6% to 7.1%. The current quarter sits inside that band.

American Healthcare REIT, Inc.'s operating margin is 6.2% in the Mar 26 quarter, −1.2 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged 1.6% to 7.1%. The current quarter sits inside that band.

The latest quarter's operating margin is 6.2%, −1.2 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 1.6%–7.1%, and FY25's 7.1% is the top of that band — a record year.

🚨 Why the margin moved: operating margin went −1.2 pp year on year while gross margin went +3.3 pp — the loss came mostly from the gross line: input costs and pricing.

Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.

→ Margins slipped — did that reach the bottom line? Next: profit null in the latest quarter.

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

American Healthcare REIT, Inc. earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.1 B. That is 3.1% of the quarter's revenue. The same quarter a year earlier lost $0.01 B. 5 of the last 12 reported quarters were loss-making.

American Healthcare REIT, Inc. earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.1 B. That is 3.1% of the quarter's revenue. The same quarter a year earlier lost $0.01 B. 5 of the last 12 reported quarters were loss-making.

Mar 26 profit was $0.0 B, null year on year. On the full year, FY25 printed $0.1 B (null).

→ Profit rose — but did the cash follow?

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

American Healthcare REIT, Inc.'s cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $0.3 B of operating cash against $0.1 B of profit. After $0.1 B of capital spending, $0.2 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.

FY25: operating cash of $0.3 B against reported profit of $0.1 B, leaving free cash of $0.2 B after $0.1 B of capital spending.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

→ So follow the cash to where it goes. Next: $0.0 B of building over 3 years.

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

American Healthcare REIT, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $0.0 B over the last 3 fiscal years.

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

→ Does all this activity actually earn its cost of capital? Next: ROE is 4% and the ROIC − WACC spread is −4.6 pp.

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

American Healthcare REIT, Inc. earns a ROE of 2% in FY25. That is up from a trough of −6% in FY23. Return on invested capital clears the cost of that capital by −4.6 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 3.1% net margin on 0.42× asset turns.

FY25 ROE is 2%, recovered from a FY23 trough of −6% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY25): 3.1% net margin × 0.42× asset turns × 1.62× balance-sheet leverage ≈ 2.1% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 3.3% − 7.9% = a −4.6 pp spread. The 7.9% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.48.

Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.

American Healthcare REIT, Inc. paid $1.00 per share over the last four reported quarters, down 37.5% on a year ago. The most recent declaration was $0.25 for Mar 26. Against the current price of $57.7 that is a trailing yield of 1.73%, measured on dividends already paid rather than on a forecast.

American Healthcare REIT, Inc. paid $1.00 per share over the last four reported quarters, down 37.5% on a year ago. The most recent declaration was $0.25 for Mar 26. Against the current price of $57.7 that is a trailing yield of 1.73%, measured on dividends already paid rather than on a forecast.

American Healthcare REIT, Inc. paid $1.00 per share across the last four reported quarters, most recently $0.25 for Mar 26. That is down 37.5% against the same quarter a year earlier. Against the current price of $57.7 the trailing twelve months work out to 1.73% — trailing dividends measured against today's price, not a forward estimate.

→ A payout is cash leaving the business. Next: what the balance sheet looks like behind it.

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

American Healthcare REIT, Inc. carries total debt of $0.6 B against shareholder equity of $3.5 B as of Mar 26, a debt-to-equity of 0.16 — effectively unlevered. On the annual view that ratio went from 1.35 in FY21 to 0.16 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of $0.6 B against shareholder equity of $3.5 B — a debt-to-equity of 0.16. On the annual view, debt-to-equity went from 1.35 (FY21) to 0.16 (FY25). The returns on this page are earned, not borrowed.

→ Who owns this, and are they adding or leaving? Next: short interest is 11.5% of the float.

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

11.5% of American Healthcare REIT, Inc.'s tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 4.8 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 11.5% of the float is sold short, and at typical trading volumes it would take about 4.8 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

→ One last check: does the safety math agree? Next: the balance-sheet safety line.

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

American Healthcare REIT, Inc.: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

Frequently asked questions